On 27 April 2026, the US Supreme Court convened for a critical hearing regarding the liability of pesticide manufacturers, particularly concerning allegations that glyphosate, a key ingredient in the widely used Roundup herbicide, contributes to cancer risk. This case, known as *Monsanto v Durnell*, represents a significant moment in the ongoing debate over consumer safety and corporate accountability in the agricultural sector.
Glyphosate Under Scrutiny
The legal discourse centres on glyphosate, a herbicide manufactured by the former Monsanto Company, now a subsidiary of Bayer. The World Health Organization identified glyphosate as a probable human carcinogen in 2015, leading to a wave of litigation against the company. Bayer is currently embroiled in over 100,000 lawsuits from individuals who allege that exposure to glyphosate has resulted in non-Hodgkin lymphoma. The company has faced substantial financial repercussions, having paid billions in settlements and jury awards.
In the present case, plaintiffs argue that Monsanto failed to adequately warn consumers about the potential cancer risks associated with glyphosate. Bayer, for its part, maintains that its products are safe and asserts that the Environmental Protection Agency (EPA) has determined that glyphosate is “unlikely” to pose a cancer risk. The litigation raises a pivotal question: does federal law supersede state-level lawsuits that seek to hold companies accountable for product safety warnings?
Legal Arguments and Implications
During the Supreme Court proceedings, legal representatives from both sides presented their arguments. Paul Clement, representing Monsanto, emphasised that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) prevents pesticide manufacturers from altering safety warnings without EPA approval. He articulated that Congress intended for a uniform regulatory framework, arguing that allowing state-level lawsuits could disrupt this critical consistency, potentially jeopardising agricultural practices reliant on these pesticides.
Clement argued, “Ignoring Congress’ clear direction here would open the door for crippling liability and undermine the interests of farmers who depend on federally registered pesticides for their livelihood.” His statements were echoed by Sarah Harris, principal deputy solicitor general for the Department of Justice, who noted that states should not be able to contradict the EPA’s assessments.
In opposition, attorney Ashley Keller contended that FIFRA does not grant the sweeping immunity that Monsanto claims. He pointed out significant flaws in the EPA’s registration process and highlighted a 2022 ruling by the Ninth Circuit Court of Appeals, which vacated the EPA’s findings on glyphosate for not adhering to established cancer risk assessment protocols.
Public Sentiment and Protests
Outside the Supreme Court, a rally took place, drawing attention to public concerns regarding the safety of glyphosate. Activists, including the Maha movement and prominent figures such as Zen Honeycutt, founder of Moms Across America, voiced their demands for accountability from pesticide manufacturers. Protesters displayed signs with slogans like “people over poison” and “Roundup the guilty,” signalling a growing unease about the implications of glyphosate on public health.
Chellie Pingree, a Democratic representative from Maine, participated in the demonstration, reinforcing her commitment to environmental safety. She remarked, “To have an actual rally in front of the supreme court, to have so many people show up from all over the country… it’s a big day.” The turnout underscored a bipartisan call for stricter regulation of harmful chemicals in agriculture.
Legislative Context
The Supreme Court hearing coincides with discussions in the US House of Representatives regarding the new Farm Bill, formally titled HR 7567, the Farm, Food and National Security Act of 2026. Proposed amendments aim to dismantle protections that shield chemical manufacturers from lawsuits and state-level regulations concerning potentially hazardous products. This legislative effort signals a potential shift in the balance of power between corporate interests and consumer protection.
Why it Matters
The outcome of *Monsanto v Durnell* could reshape the landscape of pesticide regulation and consumer rights in the United States. A ruling in favour of Monsanto may significantly restrict consumers’ ability to seek recourse against manufacturers for health-related claims, potentially setting a precedent for other industries. Conversely, a decision that favours consumer lawsuits would empower individuals and states to hold corporations accountable for product safety, reinforcing the importance of public health in regulatory frameworks. As the case unfolds, it highlights the critical intersection between environmental stewardship, public health, and corporate accountability in contemporary society.
